Apollo Hospitals group reports 20.4 per cent growth in consolidated revenues for Q2

The Apollo Hospitals group, India's leading healthcare services provider, reported a 20.4 per cent growth in consolidated revenues to Rs7,848 million for the second-quarter of fiscal 2012.

Consolidated EBITDA grew by 18.6 per cent to Rs1,311 million and profit after tax was up at Rs550 million. The company reported a diluted EPS of Rs4.05 per share.

Consolidated revenues for the first-half of the fiscal were up by 21.4 per cent to Rs15.08 billion, while EBITDA grew 19.9 per cent to Rs2,508 million. Profit after tax added up to Rs1,096 million, a growth of 17.4 per cent.

The company reported continued healthy growth in revenues driven by increasing focus on centres of excellence in cardiology, oncology, neurosciences, orthopedics, emergency and transplants.

Its standalone pharmacies reported a 25.4 per cent increase in revenues. 
The company says a calibrated expansion with a focus on sustained growth along with margin improvement has begun to yield results. For H1 of the fiscal, the division reported EBITDA of Rs60.6 million, up from a loss of Rs2.6 million in H1 of fiscal 2011.

''We are heartened by the continued growth in revenues and earnings in our business,'' said Dr Prathap C Reddy, chairman of the group. ''Apollo has always believed in creating new capacities pan-India to bridge the huge gap that exists in the healthcare infrastructure. Our ability to sustain margins despite the addition of new beds and increasing costs due to inflation and high interest rate regime demonstrates the maturity and robustness of our business model.''